WELCOME to bigdna ltd
BigDNA Ltd is developing a patented DNA vaccine platform based upon the use of modified proprietary bacteriophages. This will allow rapid, cost effective manufacturing of vaccines, which are stable for ease of storage and transport.
BigDNA is a well capitalised company and currently has a diverse, well structured investor portfolio to allow us to develop our platform vaccine technology through phase I trials.
BigDNA has both a strong, focussed product development program built on key products and an active research arm, whose aim is to develop the core platform technology and to expand the range of vaccines delivered.
BigDNA actively seeks to work with academic and industrial partners who may be interested in research and development using our novel platform.